NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bio-Sight Capital

Bio-Sight Capital

Ibarakibs-capital.co.jp

Overview

Bio-Sight Capital is a venture capital firm based in Japan that focuses on long-term investments in the biotechnology and deep-tech sectors.

Year Founded

2002

Portfolio Companies

9

Investments

Bio-Sight Capital investments
CompanyDateStageLead
SCOHIA PHARMA, Inc.May 2026VC RoundCo-investor
LQUOMApr 2026Series BCo-investor
Ai-BrainScience Inc.Mar 2026VC RoundCo-investor
LinqMed Inc.Apr 2025Series B ExtensionCo-investor
Waqua Inc.Jul 2024VC RoundCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersIbaraki
Year Founded2002

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.